$23.730
-1.376 (-5.80%)At close
NVCT News
NVCT Events
Nuvectis Pharma Files $200M Mixed Securities Shelf
Nuvectis Pharma files $200M mixed securities shelf
Nuvectis Pharma Receives Approval for Ciprocopan to Treat Paroxysmal Nocturnal Hemoglobinuria
Nuvectis Pharma announced that ciprocopan, a once-daily oral complement Factor B inhibitor, received marketing approval from the National Medicinal Products Administration of China, or NMPA, for the treatment of patients with Paroxysmal Nocturnal Hemoglobinuria previously untreated with Complement inhibitors.
Major Averages Broadly Higher to Close Q2
The major averages had a broadly higher day to close out the second quarter as traders continue to monitor oil prices amid tensions in the Middle East. Despite geopolitical tensions, an oil-price shock earlier in the quarter, and persistent inflation concerns, the major indexes still notched one of their strongest quarterly performances in years.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Patrick Industriesand LCI Industriesin an all-stock mergerDigital Realtyin three data centers from Blackstonefor $7.8BAeroVironmentreportedand provided upbeat FY27 guidanceThe U.S. Supreme Court will hear Apple'sappeal challenging a contempt ruling in its long-running App Store dispute with Epic Games,Amazon Web Services (AMZN) isto embed AI Forward Deployed Engineers with customers2. WALL STREET CALLS:Deutsche Bank and RosenblattComcastto BuyOppenheimerGoldman Sachsand Morgan Stanleyto UnderperformBofAOlinto Underperform from BuyBMOReplimuneon higher chances of FDA approvalPiperBlockwith $100 target after analyst transfer3. AROUND THE WEB:Boeingand the Society of Professional Engineering Employees in Aerospace will begin formal contract talks ahead of October labor agreement expirations, Reuters reportsWilliamsis in advanced talks to acquire Momentum Midstream for about $5.5B from EnCap Flatrock Midstream, Bloomberg reportsFerrariand BMWare releasing new models using lightweight aluminum wiring, shifting away from using copper, Reuters saysComponent and supplier lists, and photos of iPhone 18 Pro models, are among files a ransomware group stole from Apple'sIndian supplier Tata, Reuters reportsWaymo'srobotaxis are no longer available on Uber'sapp in Phoenix, Arizona, TechCrunch says4. MOVERS:Abivaxincreased in New York after announcing resultsAevexgained after securing aRezolve AIwas higher in New York after its board of directorsSable Offshorewas lower after announcing a $100M stock andNuvectis Pharmafell after5. EARNINGS/GUIDANCE:Concentrixand cut its guidance for FY26General Millstoon July 1FactSettoon July 1Progress Softwaretoon June 30MSC Industrialtoon July 1INDEXES:The Dow rose 136.46, or 0.26%, to 52,319.20, the Nasdaq gained 393.57, or 1.52%, to 26,213.72, and the S&P 500 advanced 58.93, or 0.79%, to 7,499.36.
Major Averages Rise as S&P 500 and Nasdaq Rebound
The major averages were broadly higher near noon to close out the second quarter as traders continue to monitor oil prices amid tensions in the Middle East. The S&P 500 and Nasdaq are coming off a rebound session, while the Dow recently pushed above the 52,000 level. Despite geopolitical tensions, an oil-price shock earlier in the quarter, and persistent inflation concerns, major indexes are still on track for one of their strongest quarterly performances in years.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Patrick Industriesand LCI Industriesin an all-stock mergerDigital Realtyin three data centers from Blackstonefor $7.8BAeroVironmentreportedand provided upbeat FY27 guidanceAnthtropicfor Amazon Bedrockand Google Cloudand announced general availability of Claude models in Microsoft FoundryNCR Atleosand Brink'sshareholdersBrink's previously announced acquisition of NCR Atleos2. WALL STREET CALLS:Deutsche Bank and RosenblattComcastto BuyOppenheimerGoldman Sachsand Morgan Stanleyto UnderperformBofAOlinto Underperform from BuyBMOReplimuneon higher chances of FDA approvalPiperBlockwith $100 target after analyst transfer3. AROUND THE WEB:Williamsis in advanced talks to acquire Momentum Midstream for about $5.5B from EnCap Flatrock Midstream, Bloomberg reportsFerrariand BMWare releasing new models using lightweight aluminum wiring, shifting away from using copper, Reuters saysComponent and supplier lists, and photos of iPhone 18 Pro models, are among files a ransomware group stole from Apple'sIndian supplier Tata, Reuters reportsWaymo'srobotaxis are no longer available on Uber'sapp in Phoenix, Arizona, TechCrunch saysEchoStar'sDish DBS is preparing to file for bankruptcy after struggling with $25B in debt and years of subscriber losses, WSJ reports4. MOVERS:Abivaxincreases in New York after announcing results fromAevexgains after securing a $50MRezolve AIhigher in New York after its board of directors approved aSable Offshorelower after announcing a $100M stock and $300MNuvectis Pharmafalls after announcing a5. EARNINGS/GUIDANCE:Concentrixand cut its guidance for FY26General Millson July 1FactSeton July 1Progress Softwareon June 30MSC Industrialon July 1INDEXES:Near midday, the Dow was up 0.22%, or 117.39, to 52,300.13, the Nasdaq was up 1.21%, or 312.58, to 26,132.72, and the S&P 500 was up 0.61%, or 45.50, to 7,485.93.
Cantor Fitzgerald Sets Deal Range at $20.00-$22.00
The deal range was $20.00-$22.00. Cantor Fitzgerald acted as sole book running manager for the offering.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.